Bli medlem
Bli medlem

Du är här

2020-09-17

EQL Pharma: Approval of Phenoxymethylpenicillin EQL

Phenoxymethylpenicillin EQL is a prescription antibiotic used to treat common bacterial infections such as ear infections and Lyme disease in children and adults.

Phenoxymethylpenicillin EQL contains phenoxymethylpenicillin, a substance which has been registered as granules for oral solution/suspension in Sweden since 1978 under the trademark Kåvepenin[®]. The market for phenoxmethylpenicillin granules for oral solution/suspension is estimated to approx. SEK 20 million in total annual sales in Sweden and Denmark.

The product is expected to be launched during EQL Pharma's third financial quarter, 2021/22.

Författare EQL Pharma

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.